Verition Fund Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,647
| Closed | -$131K | – | 3086 |
|
|
2025
Q1 | $131K | Buy |
+14,647
| New | +$131K | ﹤0.01% | 2466 |
|
|
2024
Q4 | – | Sell |
-12,642
| Closed | -$102K | – | 2788 |
|
|
2024
Q3 | $102K | Sell |
12,642
-21,694
| -63% | -$175K | ﹤0.01% | 2291 |
|
|
2024
Q2 | $291K | Buy |
+34,336
| New | +$291K | ﹤0.01% | 1738 |
|
|
2023
Q1 | – | Sell |
-11,261
| Closed | -$126K | – | 2161 |
|
|
2022
Q4 | $126K | Buy |
+11,261
| New | +$126K | ﹤0.01% | 1420 |
|